Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
September 16, 2023
Proton versus photon comprehensive nodal breast irradiation
Kelly McKenna
Medical Hypotheses
|
June 13, 2020
Otoconia degeneration as a consequence of primary hyperparathyroidism
Kelly McKenna, Khalil Rahman, Kourosh Parham
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
June 28, 2026
Autism diagnosis in a complex systemic and cultural landscape: A clinical perspective
Lauren J Taylor, Kelly McKenna-Kerr
Medical Hypotheses
|
January 18, 2021
Why is primary hyperparathyroidism more severe in children?
Kelly McKenna, Nancy Street Dunbar, Kourosh Parham
Clinical Case Reports
|
December 19, 2025
Aseptic Sinusitis: A New Phenotype of Immune-Related Rhinosinusitis in the Era of Immune Checkpoint Inhibitors
Josephine Yalovitser, Kenny Nguyen, Kelly McKenna, et al.
Cancers
|
July 14, 2023
Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach
Zohaib Sherwani, Shreel Parikh, Nikhil Yegya-Raman, et al.
Ear, Nose, & Throat Journal
|
November 20, 2024
Chronic Lymphocytic Leukemia with Orbital and Sinonasal Manifestations
Donald Bennett, Ashwini Sarathy, Kelly McKenna, et al.
Frontiers in Oncology
|
February 11, 2020
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P Chao, Chris H Takimoto, Dong Dong Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2019
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
Bernhard Kiss, Nynke S van den Berg, Robert Ertsey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 14, 2021
Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
Rosalynd Upton, Allison Banuelos, Dongdong Feng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
September 16, 2023
Proton versus photon comprehensive nodal breast irradiation
Kelly McKenna
Medical Hypotheses
|
June 13, 2020
Otoconia degeneration as a consequence of primary hyperparathyroidism
Kelly McKenna, Khalil Rahman, Kourosh Parham
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
June 28, 2026
Autism diagnosis in a complex systemic and cultural landscape: A clinical perspective
Lauren J Taylor, Kelly McKenna-Kerr
Medical Hypotheses
|
January 18, 2021
Why is primary hyperparathyroidism more severe in children?
Kelly McKenna, Nancy Street Dunbar, Kourosh Parham
Clinical Case Reports
|
December 19, 2025
Aseptic Sinusitis: A New Phenotype of Immune-Related Rhinosinusitis in the Era of Immune Checkpoint Inhibitors
Josephine Yalovitser, Kenny Nguyen, Kelly McKenna, et al.
Cancers
|
July 14, 2023
Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach
Zohaib Sherwani, Shreel Parikh, Nikhil Yegya-Raman, et al.
Ear, Nose, & Throat Journal
|
November 20, 2024
Chronic Lymphocytic Leukemia with Orbital and Sinonasal Manifestations
Donald Bennett, Ashwini Sarathy, Kelly McKenna, et al.
Frontiers in Oncology
|
February 11, 2020
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P Chao, Chris H Takimoto, Dong Dong Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2019
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer
Bernhard Kiss, Nynke S van den Berg, Robert Ertsey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 14, 2021
Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
Rosalynd Upton, Allison Banuelos, Dongdong Feng, et al.
Page
of 2